Switch to:
More From Other Websites
Ligand Pharmaceuticals: Biotech's Jack Of All Trades Mar 25 2015
Science, patients driving rare disease drug research surge Mar 25 2015
Science, patients driving rare disease drug research surge Mar 25 2015
Johnson & Johnson May See EPS Drag Through 2018 Mar 24 2015
Novartis Reports Positive Data on Psoriasis Drug Cosentyx - Analyst Blog Mar 23 2015
11 Promising New Drugs Expected to Make Billions in Sales Mar 23 2015
Eminence Capital Downs Position in Valeant Pharmaceuticals Mar 23 2015
Rationale for the Pharmacyclics–AbbVie Merger Mar 23 2015
Week in Review: Big deals, lawsuits and bankruptcies dominate the news Mar 22 2015
Novartis' Cosentyx(TM) two-year data shows sustained effect and favorable safety profile in... Mar 21 2015
​Judge rejects Amgen bid to stop biosimilar drug Mar 20 2015
New Novartis data shows Cosentyx(TM) is significantly superior to Stelara® and clears skin (PASI... Mar 20 2015
Amgen Loses Bid to Block a Biosimilar Version of its Best-Selling Drug Mar 20 2015
Fast-growing Triad technology firm makes acquisition, receives $20M infusion of capital Mar 19 2015
Judge Denies Amgen's Request to Block Novartis's Biosimilar of Neupogen Mar 19 2015
5 Breakout Stocks to Trade for Gains After the Fed's Bombshell Mar 19 2015
Novartis' Jakavi Gets EC Approval for Polycythemia Vera - Analyst Blog Mar 18 2015
To sell or not to sell: United Therapeutics faces choice with potential fast-track drug voucher Mar 18 2015
Novartis Division is Charged with Sex Discrimination by Former Employees Mar 18 2015
Pharmalot.. Pharmalittle: We're Catching Up On Novartis, Actavis and Lots More!! Mar 18 2015


Add Notes, Comments

If you want to ask a question, or report a bug, please create a support ticket.

User Comments

No comment yet


Get WordPress Plugins for easy affiliate links on Stock Tickers and Guru Names | Earn affiliate commissions by embedding GuruFocus Charts
GuruFocus Affiliate Program: Earn up to $400 per referral. ( Learn More)
Free 7-day Trial
FEEDBACK